Journal of Bioequivalence & Bioavailability · 2014 · 45 citations · 58 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryNanoparticle Drug DeliveryNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignNanoparticle FormulationsOral NanocarriersSolubility EnhancementAqueous Solubility ImprovementCyclodextrin Inclusion ComplexesLow SolubilityMicelle Drug DeliveryNanoparticle-mediated Bioavailability EnhancementNanoparticlesOral Drug Delivery SystemsRelative Oral Bioavailability
Curcumin, the major component of common food spice, turmeric, is a potential compound for the treatment and prevention of a wide variety of human diseases and has wide spectrum of biological and pharmacological activities. Various studies have proven the safety and efficacy of curcumin at very high doses; however the relative bioavailability of curcumin is of major concern. It has extremely low aqueous solubility and it is still unclear if it metabolizes into active or inactive metabolites. In this review, we have discussed the various novel drug delivery systems of curcumin such as various nanoparticles, micellar formulations, liposomes and cyclodextrin inclusion complexes that have been reported in order to improve the solubility, bioavailability and efficacy of curcumin.
58
Anticancer potential of curcumin: preclinical and clinical studies.
Bharat B. Aggarwal, Anushree Kumar, Alok C. Bharti · PubMed · 2003 · 2.6K citations
Medicine, Oncology, Pharmacology +15
Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations
Medicine, Oncology, Pharmacology +10
Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers
Guido Shoba, David C. Joy, Thangam Joseph et al. · Planta Medica · 1998 · 1.9K citations
Dose escalation of a curcuminoid formulation
Christopher D. Lao, Mack T. Ruffin, Daniel P. Normolle et al. · BMC Complementary and Alternative Medicine · 2006 · 1.4K citations · Full text
Pharmacy, Pharmacology, Toxicology +13